nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cost-effectiveness in the treatment of schizophrenia
|
Knapp, MRJ |
|
1996 |
11 |
3 |
p. 137-143 7 p. |
artikel |
2 |
Cost-utility in CNS drug trials
|
Ziegler, F |
|
1996 |
11 |
3 |
p. 159-164 6 p. |
artikel |
3 |
Designing dementia treatment studies: Diagnosis, efficacy criteria, and duration
|
Spiegel, R |
|
1996 |
11 |
3 |
p. 149-154 6 p. |
artikel |
4 |
Key considerations for long-term studies with anxiolytics
|
Placchi, M |
|
1996 |
11 |
3 |
p. 144-148 5 p. |
artikel |
5 |
Long-term studies in depression — relapse, recurrence, and reliability of outcome measures: Discussion
|
Sitsen, JMA |
|
1996 |
11 |
3 |
p. 120-122 3 p. |
artikel |
6 |
Long-term studies in depression — relapse versus remission. Long-term studies with antidepressants — methodological aspects for consideration
|
Pedersen, V |
|
1996 |
11 |
3 |
p. 116-119 4 p. |
artikel |
7 |
Long-term studies of antipsychotic drugs in schizophrenia
|
Lewander, T |
|
1996 |
11 |
3 |
p. 127-134 8 p. |
artikel |
8 |
Long-term studies of antipsychotic drugs in schizophrenia — discussion
|
Möller, HJ |
|
1996 |
11 |
3 |
p. 135-136 2 p. |
artikel |
9 |
Measuring patient benefit in mental illness
|
Gudex, C |
|
1996 |
11 |
3 |
p. 155-158 4 p. |
artikel |
10 |
Methodological approaches to the long-term study of antidepressants
|
Rouillon, F |
|
1996 |
11 |
3 |
p. 109-115 7 p. |
artikel |
11 |
Quality of life measurements in major depression
|
Bech, P |
|
1996 |
11 |
3 |
p. 123-126 4 p. |
artikel |